
Nerveli
Mobile app for chronic pain combining symptom tracking with guided behavioral therapy tools.
- Company
- Dallas, TX, USUnited States
Nerveli is a mobile application for chronic pain tracking and guided self-management. Its stated lines of business are direct-to-individual support and programs for providers, employers, and payors.
The product records symptoms, stress, sleep, and daily patterns and delivers guided exercises informed by cognitive behavioral therapy with daily educational material. It differs from appointment-centered care by operating daily outside the clinic for individuals with chronic pain and the organizations that serve them.
Similar Companies

Neurent Medical
neuromark.com

Nervonik
nervonik.com

ANDPAD
andpad.jp

AlayaCare
alayacare.com

Asceneuron
asceneuron.com

Npixel
npixel.co.kr

Nori
nori.ai

Ouchie

Nearpod
nearpod.com
Evoke
evokeclinic.co

Gentle Neuro
gentleneuro.com

Nourish
nourish.com

Agilitas
agilitas.in

Theranica
theranica.com

NeuraLace Medical
Nervos Network
nervos.org

N-Level
nlevel.de

Chapter.run
chapter.show

ReviMo
revimo.care

Reneurocell Therapeutics
reneurocell.com
Quick Facts
Who are Nerveli's competitors?
Companies similar to Nerveli include Neurent Medical, Nervonik, ANDPAD and AlayaCare.
When was Nerveli founded?
Nerveli was founded in 2022.
Where is Nerveli's headquarters located?
Nerveli's headquarters is located in Dallas, TX, US.
When was Nerveli's last funding round?
Nerveli's most recent funding round was for $20k (USD) in September 2024.
How much disclosed funding has Nerveli raised?
As of Sep 9, 2024, Nerveli has disclosed funding of $20k (USD). Undisclosed round amounts are excluded.
Classification
- Ownership
- Headquarters
- Dallas, Texas, United States
- SEC CIK
- 0002084682
- EIN
- 88-3541675
